Effect of hypophysectomy on the proliferation and differentiation of rat bone marrow stromal cells.

Conditions such as estrogen deficiency, skeletal unloading, and aging have all been demonstrated to have various effects on the proliferation and differentiation of bone marrow stroma-derived osteoprogenitor cells. Here we have sought to examine the effects of pituitary hormone deficiency on the proliferation and the differentiation of these osteoprogenitor cells using the hypophysectomized (HX) rat as a model. In the present study, we use an in vitro culture system to examine the effects of HX on the osteogenic potential of rat bone marrow stroma. With the intact animal as a control, we used [3H]thymidine incorporation and cell number as indexes of proliferation. We also measured alkaline phosphatase enzyme activity, relative levels of osteocalcin expression with RT-PCR, and osteopontin and bone sialoprotein steady-state levels by Northern blot to delineate the effect on differentiation. Our results indicate that osteoprogenitor cells exposed to a pituitary hormone-deficient environment in vivo demonstrate an enhanced proliferative capacity and also exhibit an augmented expression of differentiation markers when exposed to an optimal environment in vitro.

[1]  J. Aloia,et al.  Histologic evidence: Growth hormone completely prevents reduction in cortical bone gain and partially prevents cancellous osteopenia in the tibia of hypophysectomized rats , 1997, The Anatomical record.

[2]  E. R. Sánchez,et al.  Enhancement of glucocorticoid receptor-mediated gene expression by cellular stress: evidence for the involvement of a heat shock-initiated factor or process during recovery from stress. , 1996, Cell stress & chaperones.

[3]  R. Turner,et al.  Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. , 1995, Endocrinology.

[4]  J. Aubin,et al.  Osteoblast and chondroblast differentiation. , 1995, Bone.

[5]  J. Aloia,et al.  Skeletal alterations in hypophysectomized rats: I. A histomorphometric study on tibial cancellous bone , 1995, The Anatomical record.

[6]  J. Aloia,et al.  Skeletal alterations in hypophysectomized rats: II. A histomorphometric study on tibial cortical bone , 1995, The Anatomical record.

[7]  A. Scutt,et al.  Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: Induction of a transition from nonadherent to adherent osteoblast precursors , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  J. Fleet,et al.  Identification of osteocalcin mrna in nonosteoid tissue of rats and humans by reverse transcription—polymerase chain reaction , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  L. Quarles,et al.  Molecular to pharmacologic control of osteoblast proliferation and differentiation , 1994, Journal of cellular biochemistry.

[10]  J. Sodek,et al.  Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  J. Merregaert,et al.  Characterization of the stromal osteogenic cell line MN7: mRNA steady‐state level of selected osteogenic markers depends on cell density and is influenced by 17β‐estradiol , 1994 .

[12]  B. Shenker,et al.  Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. , 1994, Developmental biology.

[13]  Su‐Li Cheng,et al.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. , 1994, Endocrinology.

[14]  G S Stein,et al.  Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. , 1993, Endocrine reviews.

[15]  H. Werner,et al.  Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. , 1993, Journal of molecular endocrinology.

[16]  E. Wingender,et al.  New perspectives in the differentiation of bone-forming cells. , 1992, BioFactors.

[17]  T. Martin,et al.  Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. , 1991, Endocrinology.

[18]  I. Bérczi,et al.  Pituitary dependence of bone marrow function , 1989, British journal of haematology.

[19]  J N Beresford,et al.  Osteogenic stem cells and the stromal system of bone and marrow. , 1989, Clinical orthopaedics and related research.

[20]  J. Aubin,et al.  Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. , 1987, Endocrinology.

[21]  N. E. Sullivan,et al.  Matrix-induced endochondral bone differentiation: influence of hypophysectomy, growth hormone, and thyroid-stimulating hormone. , 1980, Endocrinology.

[22]  M. Urist,et al.  Growth Hormone Dependent Matrix-Induced Heterotopic Bone Formation 1 , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  N. Kember GROWTH HORMONE AND CARTILAGE CELL DIVISION IN HYPOPHYSECTOMIZED RATS , 1971, Cell and tissue kinetics.